Broad-spectrum sunscreen use and the development of new nevi in white children. A randomized controlled trial

JAMA

Volumn 283, Issue 22, 2000, Pages 2955-2960

  Gallagher, Richard P ^a,b,c   Rivers, Jason K ^c   Lee, Tim K ^a   Bajdik, Chris D ^a,b   McLean, David I ^c   Coldman, Andrew J ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SUNSCREEN;

ARTICLE; CANCER CONTROL; CANCER PREVENTION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LENTIGO; MAJOR CLINICAL STUDY; MALE; MELANOMA; NEVUS; OUTCOMES RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

EID: 0034647311     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.283.22.2955     Document Type: Article

References (38)

1. Holman CD, Armstrong BK. Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. J Natl Cancer Inst. 1984;72:257-266.
2. Holly EA, Kelly JW, Shpall SN, Chiu SH. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol. 1987;17:459-468. 3.
3. Marrett LD, King WD, Walter SD. From L. Use of host factors to identify people at high risk for cutaneous malignant melanoma [published correction appears in CMAJ . 1992;147:1764]. CMAJ. 1992;147: 445-453.
4. Marrett LD, King WD, Walter SD. From L. Use of host factors to identify people at high risk for cutaneous malignant melanoma [published correction appears in CMAJ . 1992;147:1764]. CMAJ. 1992;147: 445-453.
5. Grob JJ, Gouvernet J, Aymar D, et al. Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma. Cancer. 1990;66:387-395.
6. Green A, MacLennan R, Siskind V. Common acquired naevi and the risk of malignant melanoma. Int J Cancer. 1985;35:297-300.
7. Osterlind A, Tucker MA, Hou-Jensen K, Stone BJ, Engholm G, Jensen OM. The Danish case-control study of cutaneous malignant melanoma, I: importance of host factors. Int J Cancer. 1988;42:200-206.
8. Skender-Kalnenas TM, English DR, Heenan PJ. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? J Am Acad Dermatol. 1995; 33:1000-1007.
9. Kruger S, Garbe C, Buttner P, Stadler R, Guggenmoos-Holzmann I, Orfanos CE. Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. J Am Acad Dermatol. 1992;26:920-926.
10. Weinstock MA, Colditz GA, Willett WC, et al. Moles and site-specific risk of nonfamilial cutaneous malignant melanoma in women. J Natl Cancer Inst. 1989; 81:948-952.
11. Rivers JK, Frederiksen PC, Dibdin C. A prevalence survey of dermatoses in the Australian neonate. J Am Acad Dermatol. 1990;23:77-81.
12. Kroon S, Clemmensen OJ, Hastrup N. Incidence of congenital melanocytic nevi in newborn babies in Denmark. J Am Acad Dermatol. 1987;17:422-426.
13. Harrison SL, MacLennan R, Speare R, Wronski I. Sun exposure and melanocytic naevi in young Australian children. Lancet. 1994;344:1529-1532.
14. Gallagher RP, McLean DI, Yang CP, et al. Suntan, sunburn, and pigmentation factors and the frequency of acquired melanocytic nevi in children. Arch Dermatol. 1990;126:770-776.
15. Pope DJ, Sorahan T, Marsden JR, Ball PM, Grimley RP, Peck IM. Benign pigmented nevi in children. Arch Dermatol. 1992;128:1201-1206.
16. Coombs BD, Sharples KJ, Cooke KR, Skegg DC, Elwood JM. Variation and covariates of the number of benign nevi in adolescents. Am J Epidemiol. 1992; 136:344-355.
17. English DR, Armstrong BK. Melanocytic nevi in children, I: anatomic sites and demographic and host factors. Am J Epidemiol. 1994;139:390-401.
18. Newton-Bishop JA, Bataille V, Pinney E, Bishop DT. Family studies in melanoma: identification of the atypical mole syndrome (AMS) phenotype. Melanoma Res. 1994;4:199-206.
19. MacKie RM, McHenry P, Hole D. Accelerated detection with prospective surveillance for cutaneous malignant melanoma in high-risk groups. Lancet. 1993; 341:1618-1620.
20. Kelly JW, Rivers JK, MacLennan R, Harrison S, Lewis AE, Tate BJ. Sunlight: a major factor associated with the development of melanocytic nevi in Australian schoolchildren. J Am Acad Dermatol. 1994;30: 40-48.
21. Gallagher RP, Rivers JK, Yang CP, McLean DI, Coldman AJ, Silver HK. Melanocytic nevus density in Asian, Indo-Pakistani, and white children: The Vancouver Mole Study. J Am Acad Dermatol. 1991;25: 507-512.
22. English DR, MacLennan R, Rivers JK, Kelly J, Armstrong BK. Epidemiological studies of melanocytic naevi: protocol for identifying and recording naevi. IARC Internal Report No. 90/002. Lyon, France: International Agency for Research on Cancer; 1990.
23. Mosteller RD. Simplified calculation of body surface area [letter]. N Engl J Med. 1987;317:1098.
24. Diffey BL, Elwood JM. Tables of ambient solar ultraviolet radiation for use in epidemiological studies of malignant melanoma. In: Gallagher RP, Elwood JM, eds. Epidemiological Aspects of Cutaneous Malignant Melanoma. Boston, Mass: Kluwer Academic Publishers; 1994:81-105.
25. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer incidence in five continents. Vol 7. IARC Scientific Publication No. 143. Lyon, France: International Agency for Research on Cancer; 1997.
26. Holly EA, Aston DA, Cress RD, Ahn DK, Kristiansen JJ. Cutaneous melanoma in women, I: exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light. Am J Epidemiol. 1995;141: 923-933.
27. Holman CD, Armstrong BK, Heenan PJ. Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits. J Natl Cancer Inst. 1986; 76:403-414.
28. Elwood JM, Gallagher RP. More about: sunscreen use, wearing clothes, and number of nevi in 6-to 7-year-old European children [letter]. J Natl Cancer Inst. 1999;91:1164-1166.
29. Autier P, Dore JF, Schifflers E, et al, for the EORTC Melanoma Cooperative Group. Melanoma and use of sunscreens: an EORTC case-control study in Germany, Belgium, and France. Int J Cancer. 1995;61: 749-755.
30. Westerdahl J, Olsson H, Masback A, Ingvar C, Jonsson N. Is the use of sunscreens a risk factor for malignant melanoma? Melanoma Res. 1995;5:59-65.
31. Beitner H, Norell SE, Ringborg U, Wennersten G, Mattson B. Malignant melanoma: aetiological importance of individual pigmentation and sun exposure. Br J Dermatol. 1990;122:43-51.
32. Autier P, Dore JF, Cattaruzza MS, et al, for the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group. Sunscreen use, wearing clothes, and number of nevi in 6-to 7-year-old European children. J Natl Cancer Inst. 1998; 90:1873-1880.
33. Autier P, Dore JF, Negrier S, et al. Sunscreen use and duration of sun exposure, a double-blind, randomized trial. J Natl Cancer Inst. 1999;91:1304-1309.
34. Luther H, Altmeyer P, Garbe C, et al. Increase of melanocytic nevus counts in children during 5 years of follow-up and analysis of associated factors. Arch Dermatol. 1996;132:1473-1478.
35. White E, Kirkpatrick CS, Lee JA. Case-control study of malignant melanoma in Washington State, I: constitutional factors and sun exposure. Am J Epidemiol. 1994;139:857-868.
36. Elwood JM, Gallagher RP, Hill GB, Spinelli JJ, Pearson JC, Threlfall W. Pigmentation and skin reaction to sun as risk factors for cutaneous melanoma: Western Canada Melanoma Study. BMJ (Clin Res Ed). 1984; 288:99-102.
37. Holly EA, Aston DA, Cress RD, Ahn DK, Kristiansen JJ. Cutaneous melanoma in women, II: phenotypic characteristics and other host-related factors. Am J Epidemiol. 1995;141:934-942.
38. Chen YT, Dubrow R, Holford TR, et al. Malignant melanoma risk factors by anatomic site: a case-control study and polychotomous logistic regression analysis. Int J Cancer. 1996;67:636-643.